Mobile Phone Daily Alarm To Improve Compliance Of Intranasal Corticosteroid Among Allergic Rhinitis Patients.

Not Applicable

• Conditions: Rhinitis, Allergic; Compliance, Medication
• Interventions: Other: Mobile phone alarm reminder

• Registration Number: NCT05286944
• Lead Sponsor: National University of Malaysia

Brief Summary

This is a randomized controlled trial to compare the compliance of allergic rhinitis patients towards intranasal steroids between those who use mobile daily alarm reminder and those who do not.

Detailed Description

In this single blinded RCT, adults with allergic rhinitis are randomized into either he intervention or control arm. The intervention involves installing an alarm with a prerecorded nmessage "Have you take your intranasal steroids" which will automatically ring every day on the patients mobile phone. The control arm do not have any alarm set up. Both groups are offered counseling and education regarding the importance of compliance to intranasal steroid upon recruitment. Daily reminder to take medication may eliminate reason for forgetting medication schedule, hence, improve compliance towards INCS among patients with allergic rhinitis. This study aims to assess the effectiveness of using daily mobile alarm on patient's compliance towards INCS.

Study Timeline

• Study Start: 2020-01-19
• Status Verified: 2021-03
• Study First Submitted: 2022-03-10
• Study First Submitted QC: 2022-03-10
• Last Update Submitted: 2022-03-10
• Study First Posted: 2022-03-18
• Last Update Posted: 2022-03-18
• Primary Completion: 2022-06-22
• Study Completion: 2022-06-22

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 207

Inclusion Criteria

• • Patients aged 15 years old to 60 years old with persistent AR

  • Positive SPT towards DF, DP, BT, cockroach, Aspergillus, Cat fur
  • Own and able to operate functioning mobile smartphone with built in alarm
  • Able to understand simple instructions
  • Patients who can read in English and Malay
  • Newly diagnosed AR or previous patients who only take intranasal corticosteroid less than 4 times per week

Exclusion Criteria

• • Patients on immunotherapy

  • Patients with mild intermittent AR
  • Pregnant patients
  • Patient with psychiatric illness
  • Patients with gross anatomical obstruction (severe DNS, gross polyposis, nasal tumour)
  • Chronic rhinosinusitis(CRS) with or without nasal polyposis
  • Patients who have adverse reaction towards INCS
  • Patients with severe hearing loss

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Mobile daily alarm	Mobile phone alarm reminder	A mobile smartphone with functioning alarm system and solely owned by the patient. The alarm will be set by the second investigator to alert the participant between 6am - 10am (based on participant's preference) in the morning daily. A recorded dual-language (English and Malay version) tone for alarm mobile phone will be used. Apart from that participants are also counseled and educated about allergic rhinitis and are also asked to fill up self monitored adherence card to document their nasal steroid intake.

Primary Outcome Measures

Name	Time	Method
Compliance	30 days	Compliance was taken as 2/3rd use of INCS (20 days out of 30) = 20 x 0.38 = 7.6 g reduced weight.

Trial Locations

Locations (1)

Universiti Kebangsaan Malaysia Medical center; 🇲🇾 Kuala Lumpur, WP Kuala Lumpur, Malaysia